Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
Solid organ and hematopoietic cell transplantations are radical therapies for fatal conditions. However, post-transplant immune complications, including graft rejection and graft-versus-host disease (GVHD), limit the extended use of these therapies. Current treatment strategies in post-transplantation mainly rely on the use of nonspecific immunosuppressants that can lead to a wide range of adverse effects including cytomegalovirus infections and leukemia relapse.
Dr. Joo's laboratory uses cutting-edge technologies to understand cellular and molecular mechanisms of allograft rejection and GVHD. Dr. Joo's laboratory further investigates how to promote and maintain alloantigen-specific immune suppression in transplantation patients without interfering with host immunity against microbial infections and cancer.
The ultimate goal of Dr. Joo's research is to improve current post-transplantation treatments and diagnostic tools for rejection. Data from these studies will contribute to the rational design of therapeutics for post-transplantation complications.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.